NEU 4.29% $17.03 neuren pharmaceuticals limited

ANAVEX MEETS ENDPOINTS PHASE2 RETT, page-128

  1. 1,016 Posts.
    lightbulb Created with Sketch. 378
    Despite my view that this is worth $10b USD at a bare minimum, I think a major roadblock still exists and is in fact "the" major roadblock.

    I know that this has been covered numerous times but I am not convinced that the contract we signed with Acadia and subsequent amendments that aligned to the ROW deal are good for us or any prospective acquirer.

    They are too restrictive and a BP (or their legal time to be precise) will likely work this out in the course of any DD process.

    I just have this horrible feeling that despite Jon's assurances, the wording of the contract is not favourable - it leaves room for Acadia to block Neuren, if they were to go alone, or BP, were Neuren acquired.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$17.03
Change
0.700(4.29%)
Mkt cap ! $2.176B
Open High Low Value Volume
$16.49 $17.21 $16.44 $11.40M 677.5K

Buyers (Bids)

No. Vol. Price($)
1 4624 $17.02
 

Sellers (Offers)

Price($) Vol. No.
$17.05 20000 1
View Market Depth
Last trade - 16.10pm 12/11/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.